Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical Applications | CLINICAL LUNG CANCER |